已收录 268921 条政策
 政策提纲
  • 暂无提纲
Cell-free DNA 5-hydroxymethylcytosine is highly sensitive for MRD assessment in acute myeloid leukemia
[摘要] Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML). However, MRD cannot be detected in many patients using current methods. We developed a highly sensitive 5-hydroxymethylcytosine (5hmC) signature in cell-free DNA by analyzing 115 AML patients and 86 controls. The 5hmC method detected MRD in 20 of 29 patients with negative MRD by multiparameter flow cytometry and 11 of 14 patients with negative MRD by molecular methods. MRD detection by the 5hmC method was significantly associated with relapse-free survival. This novel method can be used in most AML patients and may significantly impact AML patient management.
[发布日期] 2023-08-04 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Cell-free DNA;5-hydroxymethylcytosine;Acute myeloid leukemia;Measurable residual disease [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文